Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects

Meloxicam (MLX) is widely applied as a therapy for rheumatoid arthritis (RA); however, it takes far too long to reach its peak plasma concentration for a quick onset effect, and gastrointestinal toxicity has been observed in RA patients taking it. To solve these problems, we designed MLX solid nanop...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Main Authors: Noriaki Nagai (Author), Fumihiko Ogata (Author), Hiroko Otake (Author), Naohito Kawasaki (Author)
Format: Bog
Udgivet: MDPI AG, 2020-04-01T00:00:00Z.
Fag:
Online adgang:Connect to this object online.
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Internet

Connect to this object online.

3rd Floor Main Library

Detaljer om beholdninger fra 3rd Floor Main Library
Klassifikationsnummer: A1234.567
Kopi 1 Tilgængelig